Search by Drug Name or NDC
NDC 70710-1344-05 Ramelteon 8 mg/1 Details
Ramelteon 8 mg/1
Ramelteon is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is RAMELTEON.
MedlinePlus Drug Summary
Ramelteon is used to help patients who have sleep-onset insomnia (difficulty falling asleep) fall asleep more quickly. Ramelteon is in a class of medications called melatonin receptor agonists. It works similarly to melatonin, a natural substance in the brain that is needed for sleep.
Related Packages: 70710-1344-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Ramelteon
Product Information
| NDC | 70710-1344 |
|---|---|
| Product ID | 70710-1344_6bc89997-a72b-415e-93d9-442ce2579bca |
| Associated GPIs | 60250060000320 |
| GCN Sequence Number | 059509 |
| GCN Sequence Number Description | ramelteon TABLET 8 MG ORAL |
| HIC3 | H8B |
| HIC3 Description | HYPNOTICS, MELATONIN MT1/MT2 RECEPTOR AGONISTS |
| GCN | 25202 |
| HICL Sequence Number | 033126 |
| HICL Sequence Number Description | RAMELTEON |
| Brand/Generic | Generic |
| Proprietary Name | Ramelteon |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Ramelteon |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | RAMELTEON |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Melatonin Receptor Agonist [EPC], Melatonin Receptor Agonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211567 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1344-05 (70710134405)
| NDC Package Code | 70710-1344-5 |
|---|---|
| Billing NDC | 70710134405 |
| Package | 500 TABLET in 1 BOTTLE (70710-1344-5) |
| Marketing Start Date | 2019-07-23 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |